272 related articles for article (PubMed ID: 34505951)
1. The Nano-War Against Complement Proteins.
Wang Z; Brenner JS
AAPS J; 2021 Sep; 23(5):105. PubMed ID: 34505951
[TBL] [Abstract][Full Text] [Related]
2. Complement activation by drug carriers and particulate pharmaceuticals: Principles, challenges and opportunities.
Moghimi SM; Simberg D; Papini E; Farhangrazi ZS
Adv Drug Deliv Rev; 2020; 157():83-95. PubMed ID: 32389761
[TBL] [Abstract][Full Text] [Related]
3. Combating Complement's Deleterious Effects on Nanomedicine by Conjugating Complement Regulatory Proteins to Nanoparticles.
Wang Z; Hood ED; Nong J; Ding J; Marcos-Contreras OA; Glassman PM; Rubey KM; Zaleski M; Espy CL; Gullipali D; Miwa T; Muzykantov VR; Song WC; Myerson JW; Brenner JS
Adv Mater; 2022 Feb; 34(8):e2107070. PubMed ID: 34910334
[TBL] [Abstract][Full Text] [Related]
4. The Advancement and Obstacles in Improving the Stability of Nanocarriers for Precision Drug Delivery in the Field of Nanomedicine.
Mahajan K; Bhattacharya S
Curr Top Med Chem; 2024; 24(8):686-721. PubMed ID: 38409730
[TBL] [Abstract][Full Text] [Related]
5. Renal clearable nanocarriers: Overcoming the physiological barriers for precise drug delivery and clearance.
Peng C; Huang Y; Zheng J
J Control Release; 2020 Jun; 322():64-80. PubMed ID: 32194171
[TBL] [Abstract][Full Text] [Related]
6. Recent trends of nanomedicinal approaches in clinics.
Dilnawaz F; Acharya S; Sahoo SK
Int J Pharm; 2018 Mar; 538(1-2):263-278. PubMed ID: 29339248
[TBL] [Abstract][Full Text] [Related]
7. pH-sensitive nano-systems for drug delivery in cancer therapy.
Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
[TBL] [Abstract][Full Text] [Related]
8. Nanomedicine as a non-invasive strategy for drug delivery across the blood brain barrier.
Tam VH; Sosa C; Liu R; Yao N; Priestley RD
Int J Pharm; 2016 Dec; 515(1-2):331-342. PubMed ID: 27769885
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional nanocarriers.
Torchilin VP
Adv Drug Deliv Rev; 2006 Dec; 58(14):1532-55. PubMed ID: 17092599
[TBL] [Abstract][Full Text] [Related]
10. Actively targeted nanocarriers for drug delivery to cancer cells.
Biffi S; Voltan R; Bortot B; Zauli G; Secchiero P
Expert Opin Drug Deliv; 2019 May; 16(5):481-496. PubMed ID: 30955393
[TBL] [Abstract][Full Text] [Related]
11. Silica-Based Nanoparticles for Biomedical Applications: From Nanocarriers to Biomodulators.
Yang Y; Zhang M; Song H; Yu C
Acc Chem Res; 2020 Aug; 53(8):1545-1556. PubMed ID: 32667182
[TBL] [Abstract][Full Text] [Related]
12. Delivery and targeting of nanoparticles into hair follicles.
Fang CL; Aljuffali IA; Li YC; Fang JY
Ther Deliv; 2014; 5(9):991-1006. PubMed ID: 25375342
[TBL] [Abstract][Full Text] [Related]
13. Insights into cellular uptake of nanoparticles.
Kafshgari MH; Harding FJ; Voelcker NH
Curr Drug Deliv; 2015; 12(1):63-77. PubMed ID: 25146441
[TBL] [Abstract][Full Text] [Related]
14. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
15. Ocular drug delivery: nanomedicine applications.
Vandervoort J; Ludwig A
Nanomedicine (Lond); 2007 Feb; 2(1):11-21. PubMed ID: 17716187
[TBL] [Abstract][Full Text] [Related]
16. Mesoporous silica nanoparticles as nanocarriers.
Wu SH; Hung Y; Mou CY
Chem Commun (Camb); 2011 Sep; 47(36):9972-85. PubMed ID: 21716992
[TBL] [Abstract][Full Text] [Related]
17. Targeted nanomedicine: Lessons learned and future directions.
Veiga N; Diesendruck Y; Peer D
J Control Release; 2023 Mar; 355():446-457. PubMed ID: 36773958
[TBL] [Abstract][Full Text] [Related]
18. Cell membrane-camouflaged nanoparticles for drug delivery.
Luk BT; Zhang L
J Control Release; 2015 Dec; 220(Pt B):600-7. PubMed ID: 26210440
[TBL] [Abstract][Full Text] [Related]
19. Nanocarriers for the Delivery of Medical, Veterinary, and Agricultural Active Ingredients.
Chariou PL; Ortega-Rivera OA; Steinmetz NF
ACS Nano; 2020 Mar; 14(3):2678-2701. PubMed ID: 32125825
[TBL] [Abstract][Full Text] [Related]
20. Development of drug delivery systems based on layered hydroxides for nanomedicine.
Barahuie F; Hussein MZ; Fakurazi S; Zainal Z
Int J Mol Sci; 2014 May; 15(5):7750-86. PubMed ID: 24802876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
